Yidong Wang1, Bingruo Wu1, Emily Farrar2, Wendy Lui1, Pengfei Lu1, Donghong Zhang1, Christina M Alfieri3, Kai Mao4, Ming Chu5, Di Yang5, Di Xu5, Michael Rauchman6, Verdon Taylor7, Simon J Conway8, Katherine E Yutzey3, Jonathan T Butcher2, Bin Zhou1,5. 1. Department of Genetics, Pediatrics, and Medicine (Cardiology), Wilf Cardiovascular Research Institute, Albert Einstein College of Medicine, Price 420, 1301 Morris Park Avenue, Bronx, NY 14061, USA. 2. Department of Biomedical Engineering, Cornell University, Ithaca, NY, USA. 3. Division of Molecular Cardiovascular Biology, Cincinnati Children's Medical Centre, Cincinnati, OH, USA. 4. Institute for Aging Research, Albert Einstein College of Medicine, Bronx, NY, USA. 5. Department of Medicine and Geriatrics (Cardiology), First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. 6. Department of Internal Medicine, Saint Louis University, St. Louis, MO, USA. 7. Department of Biomedicine, University of Basel, Basel, Switzerland. 8. Department of Paediatrics, Indiana University, Indianapolis, IN, USA.
Abstract
AIMS: Congenital anomalies of arterial valves are common birth defects, leading to valvar stenosis. With no pharmaceutical treatment that can prevent the disease progression, prosthetic replacement is the only choice of treatment, incurring considerable morbidity and mortality. Animal models presenting localized anomalies and stenosis of congenital arterial valves similar to that of humans are critically needed research tools to uncover developmental molecular mechanisms underlying this devastating human condition. METHODS AND RESULTS: We generated and characterized mouse models with conditionally altered Notch signalling in endothelial or interstitial cells of developing valves. Mice with inactivation of Notch1 signalling in valvar endothelial cells (VEC) developed congenital anomalies of arterial valves including bicuspid aortic valves and valvar stenosis. Notch1 signalling in VEC was required for repressing proliferation and activating apoptosis of valvar interstitial cells (VIC) after endocardial-to-mesenchymal transformation (EMT). We showed that Notch signalling regulated Tnfα expression in vivo, and Tnf signalling was necessary for apoptosis of VIC and post-EMT development of arterial valves. Furthermore, activation or inhibition of Notch signalling in cultured pig aortic VEC-promoted or suppressed apoptosis of VIC, respectively. CONCLUSION: We have now met the need of critical animal models and shown that Notch-Tnf signalling balances proliferation and apoptosis for post-EMT development of arterial valves. Our results suggest that mutations in its components may lead to congenital anomaly of aortic valves and valvar stenosis in humans. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Congenital anomalies of arterial valves are common birth defects, leading to valvar stenosis. With no pharmaceutical treatment that can prevent the disease progression, prosthetic replacement is the only choice of treatment, incurring considerable morbidity and mortality. Animal models presenting localized anomalies and stenosis of congenital arterial valves similar to that of humans are critically needed research tools to uncover developmental molecular mechanisms underlying this devastating human condition. METHODS AND RESULTS: We generated and characterized mouse models with conditionally altered Notch signalling in endothelial or interstitial cells of developing valves. Mice with inactivation of Notch1 signalling in valvar endothelial cells (VEC) developed congenital anomalies of arterial valves including bicuspid aortic valves and valvar stenosis. Notch1 signalling in VEC was required for repressing proliferation and activating apoptosis of valvar interstitial cells (VIC) after endocardial-to-mesenchymal transformation (EMT). We showed that Notch signalling regulated Tnfα expression in vivo, and Tnf signalling was necessary for apoptosis of VIC and post-EMT development of arterial valves. Furthermore, activation or inhibition of Notch signalling in cultured pig aortic VEC-promoted or suppressed apoptosis of VIC, respectively. CONCLUSION: We have now met the need of critical animal models and shown that Notch-Tnf signalling balances proliferation and apoptosis for post-EMT development of arterial valves. Our results suggest that mutations in its components may lead to congenital anomaly of aortic valves and valvar stenosis in humans. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Meritxell Nus; Donal MacGrogan; Beatriz Martínez-Poveda; Yolanda Benito; Jesús C Casanova; Francisco Fernández-Avilés; Javier Bermejo; José Luis de la Pompa Journal: Arterioscler Thromb Vasc Biol Date: 2011-04-14 Impact factor: 8.311
Authors: A M Ranger; M J Grusby; M R Hodge; E M Gravallese; F C de la Brousse; T Hoey; C Mickanin; H S Baldwin; L H Glimcher Journal: Nature Date: 1998-03-12 Impact factor: 49.962
Authors: Raimund Erbel; Victor Aboyans; Catherine Boileau; Eduardo Bossone; Roberto Di Bartolomeo; Holger Eggebrecht; Arturo Evangelista; Volkmar Falk; Herbert Frank; Oliver Gaemperli; Martin Grabenwöger; Axel Haverich; Bernard Iung; Athanasios John Manolis; Folkert Meijboom; Christoph A Nienaber; Marco Roffi; Hervé Rousseau; Udo Sechtem; Per Anton Sirnes; Regula S von Allmen; Christiaan J M Vrints Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Paige Snider; Robert B Hinton; Ricardo A Moreno-Rodriguez; Jian Wang; Rhonda Rogers; Andrew Lindsley; Fang Li; David A Ingram; Donald Menick; Loren Field; Anthony B Firulli; Jeffery D Molkentin; Roger Markwald; Simon J Conway Journal: Circ Res Date: 2008-02-22 Impact factor: 17.367
Authors: Andrew Lindsley; Paige Snider; Hongming Zhou; Rhonda Rogers; Jian Wang; Michael Olaopa; Agnieszka Kruzynska-Frejtag; Shrinagesh V Koushik; Brenda Lilly; John B E Burch; Anthony B Firulli; Simon J Conway Journal: Dev Biol Date: 2007-05-03 Impact factor: 3.582
Authors: Holly Nadorlik; Jessica L Bowman; Sara Fitzgerald-Butt; May Ling Mah; Kim L McBride; John P Kovalchin; Vidu Garg Journal: Pediatr Cardiol Date: 2017-09-25 Impact factor: 1.655
Authors: Sara N Koenig; Stephanie LaHaye; James D Feller; Patrick Rowland; Kan N Hor; Aaron J Trask; Paul Ml Janssen; Freddy Radtke; Brenda Lilly; Vidu Garg Journal: JCI Insight Date: 2017-11-02